Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic basis for clinical expression in multiple sclerosis.

L F Barcellos, J R Oksenberg, A J Green

    Brain : a Journal of Neurology
    |February 9, 2002
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Enhancement in the performance of Nb<sub>14</sub>W<sub>3</sub>O<sub>44</sub> high power anodes through P doping in the tetrahedral sites.

    Dalton transactions (Cambridge, England : 2003)·2025
    Same author

    Plastic ingestion in aquatic insects: Implications of waterbirds and landfills and association with stable isotopes.

    The Science of the total environment·2024
    Same author

    Structural and electrochemical insights into novel Wadsley Roth Nb<sub>7</sub>Ti<sub>1.5</sub>Mo<sub>1.5</sub>O<sub>25</sub> and Ta<sub>7</sub>Ti<sub>1.5</sub>Mo<sub>1.5</sub>O<sub>25</sub> anodes for Li-ion battery application.

    Dalton transactions (Cambridge, England : 2003)·2023
    Same author

    The utility of multiple genomic technologies for interpretation of modern next generation sequencing: A novel case of three FANCA gene variants resulting in autosomal recessive Fanconi anaemia.

    Blood cells, molecules & diseases·2023
    Same author

    Invertebrate dispersal by waterbird species in neotropical wetlands.

    Brazilian journal of biology = Revista brasleira de biologia·2021
    Same author

    MRI findings in blinded trials should be available to treating physicians - Commentary.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2021

    Genetic factors influence multiple sclerosis (MS) susceptibility. While early clinical manifestations show familial concordance, human leucocyte antigen (HLA)-DR2 does not appear to directly influence this concordance in MS.

    Area of Science:

    • Neuroimmunology
    • Genetics of Neurological Disorders
    • Demyelinating Diseases

    Background:

    • Multiple sclerosis (MS) is a heterogeneous demyelinating disease causing neurological disability.
    • Genetic susceptibility is known to play a role in MS etiology.
    • The influence of genetic factors on specific clinical features of MS remains unclear.

    Purpose of the Study:

    • To investigate the role of genetic factors in determining clinical features of multiple sclerosis.
    • To examine the concordance of clinical variables within MS families.
    • To evaluate the effect of human leucocyte antigen (HLA)-DR2 on clinical outcomes.

    Main Methods:

    • Studied 184 Caucasian MS families with multiple affected individuals.
    • Assessed clinical variables including age of onset, initial manifestations, and disease severity.

    Related Experiment Videos

  • Utilized intraclass correlation, Cohen's kappa, and regression models for genetic and clinical analyses, including HLA-DR2 association.
  • Main Results:

    • Significant familial concordance observed for early clinical manifestations (optic neuritis/spinal cord involvement).
    • Linkage and association to HLA-DR were detected, primarily in families with the DR2 haplotype.
    • No direct association found between HLA-DR2 and concordance of early clinical manifestations, despite DR2 association across subgroups.

    Conclusions:

    • Familial concordance for early MS manifestations exists but is not solely explained by HLA-DR2.
    • The association of DR2 suggests a common susceptibility basis for MS.
    • Non-HLA genes or epigenetic factors likely modulate MS disease expression, with potential locus heterogeneity in DR2-negative patients.